Adendra Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Adendra General Information
Description
Developer of therapeutics designed to build on new insights into dendritic cell biology. The company specializes in discovering and developing new medicines for the treatment of cancers and autoimmune diseases based on insights into the biology of dendritic cells and their ability to cross-present antigens, enabling the healthcare sector to cure cancer efficiently.
Contact Information
Website
www.adendratx.comCorporate Office
- The Gridiron Building
- Suite 6.05, 1 Pancras Square
- London N1C 4AG
- England, United Kingdom
Corporate Office
- The Gridiron Building
- Suite 6.05, 1 Pancras Square
- London N1C 4AG
- England, United Kingdom
Adendra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 12-Dec-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 07-Dec-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Adendra Comparisons
Industry
Financing
Details
Adendra Competitors (54)
One of Adendra’s 54 competitors is etherna, a Formerly VC-backed company based in Niel, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Quell Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH | ||||
| Histogen | Formerly VC-backed | San Ramon, CA | ||||
| Precigen | Formerly VC-backed | Germantown, MD |
Adendra Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Adendra Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Adendra Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cancer Research Technology | Venture Capital | Minority | ||
| The Francis Crick Institute | Accelerator/Incubator | Minority | ||
| Apple Tree Partners (ATP) | Venture Capital | Minority |
Adendra FAQs
-
When was Adendra founded?
Adendra was founded in 2021.
-
Where is Adendra headquartered?
Adendra is headquartered in London, United Kingdom.
-
What is the size of Adendra?
Adendra has 3 total employees.
-
What industry is Adendra in?
Adendra’s primary industry is Drug Discovery.
-
Is Adendra a private or public company?
Adendra is a Private company.
-
What is Adendra’s current revenue?
The current revenue for Adendra is .
-
How much funding has Adendra raised over time?
Adendra has raised $53.5M.
-
Who are Adendra’s investors?
Cancer Research Technology, The Francis Crick Institute, and Apple Tree Partners (ATP) have invested in Adendra.
-
Who are Adendra’s competitors?
etherna, Quell Therapeutics, Adimab, Histogen, and Precigen are some of the 54 competitors of Adendra.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
